About us

Future Analgesics Ltd was established in 2015 with the aim of developing drugs based on novel peptides called "purotoxins", discovered at the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences (IBCh RAS).

In the same year of 2015, the company became a member of the Skolkovo Innovation Center.

The focus of the company is the research and development of FA006, a drug candidate for the treatment of pain syndromes and chronic cough.